Skip to content

Drug interactions

Lumacaftor / ivacaftor + Sirolimus

Severity: Major

Lumacaftor / ivacaftor and Sirolimus: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lumacaftor is a strong CYP3A inducer and can lower sirolimus levels, risking loss of immunosuppression and rejection or disease control failure. Ivacaftor may weakly inhibit CYP3A and P-glycoprotein, so net effects can be unpredictable.

What this interaction means in plain words

Lumacaftor / ivacaftor and Sirolimus can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Induction of CYP3A4 (and possibly P-glycoprotein) by lumacaftor increases sirolimus clearance.

What to do

Avoid if possible. If needed, monitor sirolimus trough concentrations frequently and adjust the dose, and recheck after the CFTR modulator is stopped.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lumacaftor / ivacaftor and Sirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lumacaftor / ivacaftor with Sirolimus?

MediHelp rates the interaction as major. Lumacaftor / ivacaftor and Sirolimus can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Lumacaftor is a strong CYP3A inducer and can lower sirolimus levels, risking loss of immunosuppression and rejection or disease control failure. Ivacaftor may weakly inhibit CYP3A and P-glycoprotein, so net effects can be unpredictable.

How serious is the interaction between Lumacaftor / ivacaftor and Sirolimus?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible. If needed, monitor sirolimus trough concentrations frequently and adjust the dose, and recheck after the CFTR modulator is stopped.

What other medicines interact with Sirolimus?

MediHelp also lists interactions of Sirolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Sirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in